Aenitis Overview

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.35M

  • Investors
  • 7

Aenitis General Information

Description

Developer of a medical device designed to offer assistance for cell therapy preparations. The company's devices focus on cell therapy units and blood banks' challenges by developing bioprocessing medical devices dedicated to cell therapy manufacturing issues, including cell sorting, cell washing, and cell isolation, enabling the healthcare industry to get acoustic preparation support for cell therapies.

Contact Information

Website
www.aenitis.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Avenue Claude Vellefaux
  • Saint Louis-Hospital, Bâtiment Jean Bernard
  • 75010 Paris
  • France
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Services
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 1 Avenue Claude Vellefaux
  • Saint Louis-Hospital, Bâtiment Jean Bernard
  • 75010 Paris
  • France

Aenitis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aenitis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 14-Oct-2024 $2.35M Completed Generating Revenue
11. Later Stage VC 15-Dec-2023 Completed Generating Revenue
10. Grant 01-Jan-2021 Completed Generating Revenue
9. Debt - General 01-Jan-2020 Completed Generating Revenue
8. Grant 01-Jan-2020 Completed Generating Revenue
7. Grant 02-Dec-2019 Completed Generating Revenue
6. Grant 01-Jan-2018 Completed Generating Revenue
5. Early Stage VC 01-Jan-2018 Completed Generating Revenue
4. Early Stage VC 30-Nov-2017 $4.7M $5.87M Completed Generating Revenue
3. Angel (individual) 13-Jul-2016 $89.2K $1.17M Completed Generating Revenue
To view Aenitis’s complete valuation and funding history, request access »

Aenitis Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 55,850 $1.174274 $21.03 $21.03 1x $21.03 28.16%
To view Aenitis’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Aenitis Patents

  • 48

    Total Documents Applications and Grants

  • Total Patents Families

  • 34

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Aenitis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4617357-A1 Acoustic cell segregation method and system Pending 12-Mar-2024
WO-2025190537-A1 Acoustic cell segregation method and system Pending 12-Mar-2024
EP-4253522-A1 Acoustic method for transduction and transfection Pending 01-Apr-2022
EP-4504894-A1 Acoustic method for transduction and transfection Pending 01-Apr-2022
US-20250215416-A1 Acoustic method for transduction and transfection Pending 01-Apr-2022 C12N13/00
To view Aenitis’s complete patent history, request access »

Aenitis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aenitis Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Stamos Capital Asset Manager Minority
European Innovation Council Accelerator/Incubator Minority
Mifani Invest Venture Capital Minority
EIT Health Accelerator/Incubator
Weaving Invest Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Aenitis FAQs

  • Where is Aenitis headquartered?

    Aenitis is headquartered in Paris, France.

  • What is the size of Aenitis?

    Aenitis has 12 total employees.

  • What industry is Aenitis in?

    Aenitis’s primary industry is Other Devices and Supplies.

  • Is Aenitis a private or public company?

    Aenitis is a Private company.

  • What is Aenitis’s current revenue?

    The current revenue for Aenitis is .

  • How much funding has Aenitis raised over time?

    Aenitis has raised $11.5M.

  • Who are Aenitis’s investors?

    Stamos Capital, European Innovation Council, Mifani Invest, EIT Health, and Weaving Invest are 5 of 7 investors who have invested in Aenitis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process